表观遗传学在固体瘤中的进展和陷 临床试验
Alice Rossi1,2, Francesca Zacchi1,2, Anna Reni1
1Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University and Hospital Trust (AOUI) of Verona, 37134 Verona, Italy.
International journal of molecular sciences
|November 9, 2024
概括
表观遗传药物在固体瘤中表现有前途,特别是在与其他癌症治疗相结合时. 本综述探讨了它们的演变及其在精准医学和组合疗法中的未来潜力.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 表观遗传失调是癌症发展和进展的关键驱动因素.
- 目前的表观遗传药物在血液癌症中有效,但在固体瘤中有限.
- 药物开发和癌症生物学方面的进步为固体瘤提供了新的机会.
研究的目的:
- 审查表观遗传药物的演变,从单一疗法到组合疗法.
- 评估固体瘤中表观遗传药物的临床前和临床证据.
- 讨论优化组合疗法开发的战略.
主要方法:
- 批判性评价关于表观遗传药物开发的文献.
- 分析临床前数据和已完成/正在进行的临床试验.
- 探索组合疗法的试验设计和药物调度.
主要成果:
- 通过精密医学,表观遗传药物越来越多地被探索用于固体瘤治疗.
- 表观遗传药物具有显著的潜力,可以与化疗,放射治疗,激素治疗,向治疗和免疫治疗协同作用.
- 优化试验设计和调度对于成功的组合疗法开发至关重要.
结论:
- 表观遗传药物正在向组合疗法过渡,以提高在固体瘤中的疗效.
- 需要进一步的研究和战略性临床试验设计,才能充分发挥表观遗传疗法的潜力.
- 组合方法有望克服耐药性并改善各种癌症患者的治疗结果.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K


